These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

354 related articles for article (PubMed ID: 35069530)

  • 1. Microbiota-Meditated Immunity Abnormalities Facilitate Hepatitis B Virus Co-Infection in People Living With HIV: A Review.
    Ouyang J; Zaongo SD; Zhang X; Qi M; Hu A; Wu H; Chen Y
    Front Immunol; 2021; 12():755890. PubMed ID: 35069530
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Strategies for Hepatitis B Virus Prevention in People Living with HIV.
    Corcorran MA; Kim HN
    Curr HIV/AIDS Rep; 2023 Dec; 20(6):451-457. PubMed ID: 37837570
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment outcomes of HIV patients with hepatitis B and C virus co-infections in Southwest China: an observational cohort study.
    Jia J; Zhu Q; Deng L; Lan G; Johnson A; Chen H; Shen Z; Li J; Xing H; Ruan Y; Li J; Lu H; Vermund SH; Zhu J; Qian HZ
    Infect Dis Poverty; 2022 Jan; 11(1):7. PubMed ID: 34986877
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oral and Gut Microbial Diversity and Immune Regulation in Patients with HIV on Antiretroviral Therapy.
    Annavajhala MK; Khan SD; Sullivan SB; Shah J; Pass L; Kister K; Kunen H; Chiang V; Monnot GC; Ricupero CL; Mazur RA; Gordon P; de Jong A; Wadhwa S; Yin MT; Demmer RT; Uhlemann AC
    mSphere; 2020 Feb; 5(1):. PubMed ID: 32024712
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of hepatitis B virus infection on HIV response to antiretroviral therapy in a Chinese antiretroviral therapy center.
    Yang R; Gui X; Xiong Y; Gao SC; Yan Y
    Int J Infect Dis; 2014 Nov; 28():29-34. PubMed ID: 25236390
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatitis B virus infection is associated with impaired immunological recovery during antiretroviral therapy in the Swiss HIV cohort study.
    Wandeler G; Gsponer T; Bihl F; Bernasconi E; Cavassini M; Kovari H; Schmid P; Battegay M; Calmy A; Egger M; Furrer H; Rauch A;
    J Infect Dis; 2013 Nov; 208(9):1454-8. PubMed ID: 23901088
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proportion and factors associated with Hepatitis B viremia in antiretroviral treatment naïve and experienced HIV co-infected Ghanaian patients.
    Archampong TN; Lartey M; Sagoe KW; Obo-Akwa A; Kenu E; Gillani FS; Yang H; Boamah I; Flanigan T; Kwara A
    BMC Infect Dis; 2016 Jan; 16():14. PubMed ID: 26759172
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gut epithelial barrier dysfunction in human immunodeficiency virus-hepatitis C virus coinfected patients: Influence on innate and acquired immunity.
    Márquez M; Fernández Gutiérrez del Álamo C; Girón-González JA
    World J Gastroenterol; 2016 Jan; 22(4):1433-48. PubMed ID: 26819512
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical Outcomes during Treatment Interruptions in Human Immunodeficiency Virus-Hepatitis B Virus Co-infected Patients from Sub-Saharan Africa.
    Boyd A; Houghtaling L; Moh R; Chekaraou MA; Gabillard D; Eholié SP; Anglaret X; Zoulim F; Danel C; Lacombe K; For The Anrs Trivacan And Anrs VarBVA Studies
    Am J Trop Med Hyg; 2017 Dec; 97(6):1936-1942. PubMed ID: 29141712
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gut microbiota modulate the immune effect against hepatitis B virus infection.
    Xu D; Huang Y; Wang J
    Eur J Clin Microbiol Infect Dis; 2015 Nov; 34(11):2139-47. PubMed ID: 26272175
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gut microbiota in the innate immunity against hepatitis B virus - implication in age-dependent HBV clearance.
    Wu LL; Huang TS; Shyu YC; Wang CL; Wang HY; Chen PJ
    Curr Opin Virol; 2021 Aug; 49():194-202. PubMed ID: 34242953
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HBV and HIV viral load but not microbial translocation or immune activation are associated with liver fibrosis among patients in South Africa.
    Maponga TG; Andersson MI; van Rensburg CJ; Arends JE; Taljaard J; Preiser W; Glashoff RH
    BMC Infect Dis; 2018 May; 18(1):214. PubMed ID: 29739341
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatitis B virus and hepatitis C virus infection among HIV-1-infected injection drug users in Dali, China: prevalence and infection status in a cross-sectional study.
    Dong Y; Qiu C; Xia X; Wang J; Zhang H; Zhang X; Xu J
    Arch Virol; 2015 Apr; 160(4):929-36. PubMed ID: 25616842
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of human immunodeficiency virus, hepatitis C virus, hepatitis B virus and syphilis among individuals attending anonymous testing for HIV in Luanda, Angola.
    Guimarães Nebenzahl H; Lopes A; Castro R; Pereira F
    S Afr Med J; 2013 Jan; 103(3):186-8. PubMed ID: 23472697
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Short-term treatment outcomes in human immunodeficiency virus type-1 and hepatitis B virus co-infections.
    Sagoe KW; Duedu KO; Ziga F; Agyei AA; Adiku TK; Lartey M; Mingle JA; Arens M
    Ann Clin Microbiol Antimicrob; 2016 Jun; 15(1):38. PubMed ID: 27251610
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High Prevalence of HBV Lamivudine-Resistant Mutations in HBV/HIV Co-Infected Patients on Antiretroviral Therapy in the Area with the Highest Prevalence of HIV/HBV Co-Infection in China.
    Jia HH; Li KW; Chen QY; Wang XY; Harrison TJ; Liang SJ; Yang QL; Wang C; Hu LP; Ren CC; Fang ZL
    Intervirology; 2018; 61(3):123-132. PubMed ID: 30368502
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Microbiome of HIV-infected people.
    Dubourg G; Surenaud M; Lévy Y; Hüe S; Raoult D
    Microb Pathog; 2017 May; 106():85-93. PubMed ID: 27216237
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High seroprevalence of HBV and HCV infection in HIV-infected adults in Kigali, Rwanda.
    Rusine J; Ondoa P; Asiimwe-Kateera B; Boer KR; Uwimana JM; Mukabayire O; Zaaijer H; Mugabekazi J; Reiss P; van de Wijgert JH
    PLoS One; 2013; 8(5):e63303. PubMed ID: 23717409
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Entecavir therapy reverses gut microbiota dysbiosis induced by hepatitis B virus infection in a mouse model.
    Li X; Wu S; Du Y; Yang L; Li Y; Hong B
    Int J Antimicrob Agents; 2020 Jul; 56(1):106000. PubMed ID: 32360229
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HIV-HBV and HIV-HCV Coinfection and Liver Cancer Development.
    Hu J; Liu K; Luo J
    Cancer Treat Res; 2019; 177():231-250. PubMed ID: 30523627
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.